Atricure Inc

ATRCNASDAQ · USD
58.83USD0.00 (+0.88%)
5610

Atricure Inc (ATRC) Implied Volatility Current

ATRC implied volatility is 48%. IV Rank is 5%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking ATRC implied volatility helps you identify when options premiums on Atricure Inc are historically cheap or expensive, and where the best trades are hiding. Atricure Inc implied volatility reflects the market's expectation of future price movement: when ATRC IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Atricure Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ATRC, tracking metrics like ATRC IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ATRC signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation.

It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ATRC implied volatility sits today versus where it has been. Our scanner ranks Atricure Inc implied volatility against its historical range, surfaces extremes in ATRC IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Atricure Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
4.76%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)47.74%

IV Rank4.76%

Historical Volatility (30d)33.07%

IV - HV+14.67%

As of September 22, 2026

Trade options with IV on your side

Track ATRC IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial